
- Volume 0 0
Efflux Pumps in H Pylori
Multidrug-resistance proteins and drug-efflux pumps have been characterizedin many organisms, and they represent a widely used mechanism of drugresistance. In a recent issue of Antimicrobial Agents and Chemotherapy (April2005), investigators report results from a study of efflux pumps in Helicobacterpylori. The genome of H pylori 26695 contains 27 translocases, among whichare HP1184, which is similar to other well-characterized multidrug-resistancetranslocases, and 4 other translocases (HP0605, HP0971, HP1327, andHP1489), which are similar to outer membrane TolC proteins. Investigators performedgene knockout experiments and assessed the bacteria now lackingthese proteins for susceptibility to antibiotic and toxic compounds. The HP0605knockout mutant demonstrated increased susceptibility to novobiocin and sodiumdeoxycholate, and a double knockout of HP0605 and HP0971 hadincreased susceptibility to metronidazole.
Articles in this issue
over 20 years ago
Antibiotics, Probiotics, and Microfloraover 20 years ago
Calcium: An Essential Mineralover 20 years ago
CAN YOU READTHESE Rxs?over 20 years ago
ECKEL RECEIVES ALUMNI AWARDover 20 years ago
Cancer: Update on Biologicsover 20 years ago
Managing Chronic Pain: An Analysis of the Use of Opioidsover 20 years ago
PHARMACIST'S RIGHT TO CHOOSE?over 20 years ago
Teenage Drug Diversion—Part 2over 20 years ago
Is Altering Refills a Criminal Act?over 20 years ago
Do All SSRIs Interact the Same Way?Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.












































































































































































































